If finalized, the rule would override state laws, including those that ban reporting of medical debt on consumer credit reports ...
The Food and Drug Administration (FDA) has designated Conexxence ® (denosumab-bnht) and Bomyntra ® (denosumab-bnht) as interchangeable biosimilars to the reference products Prolia ® (denosumab) and ...
Rates for plans sold through federal Obamacare marketplaces will rise, on average, by 30% next year, according to a new analysis from the health research group KFF. States that run their own ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback